Hypoventilation in patients with Prader-Willi syndrome across the pediatric age

Catherine Chen1,2, Iulia Ioan3, Marine Thieux2,4,5

  • 1Service de pneumologie pédiatrique, Hôpital Femme Mère Enfant, Hospices, Civils de Lyon, Bron, France.

Pediatric Pulmonology
|January 5, 2024
PubMed

Insights

Alveolar hypoventilation affects 35% of children with Prader-Willi syndrome (PWS), often without symptoms. Regular screening is recommended, especially with age and growth hormone (GH) treatment, to monitor respiratory health in PWS patients.

Area of Science:

  • Pediatric Pulmonology
  • Genetics
  • Sleep Medicine

Background:

  • Prader-Willi syndrome (PWS) is a complex genetic disorder with limited data on respiratory complications.
  • Standardized respiratory follow-up for PWS patients is lacking, particularly concerning alveolar hypoventilation.

Purpose of the Study:

  • To determine the prevalence of alveolar hypoventilation in children with PWS.
  • To identify potential risk factors associated with alveolar hypoventilation in this population.

Main Methods:

  • Retrospective polysomnography (PSG) study of children with PWS (2007-2021).
  • Inclusion criteria: PSG with transcutaneous CO2 (PtcCO2) or end-tidal CO2 (ETCO2) measurements.
  • Alveolar hypoventilation defined as pCO2 ≥ 50 mmHg for ≥2% of total sleep time or >5 consecutive minutes.

Main Results:

  • 35% (20/57) of children with PWS exhibited alveolar hypoventilation.
  • Median pCO2 max was 49 mmHg; 25% of hypoventilating children were asymptomatic.
  • Higher median age and growth hormone (GH) treatment were associated with hypoventilation.

Conclusions:

  • Alveolar hypoventilation is a significant concern in pediatric PWS, potentially increasing with age and GH therapy.
  • Regular screening using oximetry-capnography is advised for all PWS patients, irrespective of sex, BMI, or apnea index.
Abstract

Related Concept Videos

Alterations in Respiration II01:30

Alterations in Respiration II

There are numerous types of normal and abnormal respiration. Based on ventilatory movements, breathing patterns are classified as regular, deep, or shallow. Examples include Biot's breathing, Cheyne-Stokes respiration, Kussmaul's breathing, hyperventilation, and hypoventilation. Each pattern is clinically significant and aids in evaluating patients.
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
869
Hyperpnea and Hyperventilation01:25

Hyperpnea and Hyperventilation

Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...
1.1K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.6K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
238
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
187
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
159